128 related articles for article (PubMed ID: 16854781)
1. Metabolism and excretion of imrecoxib in rat.
Xu H; Zhang Y; Sun Y; Zhang P; Chu F; Guo Z; Zhang H; Zhong D
Xenobiotica; 2006 May; 36(5):441-55. PubMed ID: 16854781
[TBL] [Abstract][Full Text] [Related]
2. Role of rat liver cytochrome P450 3A and 2D in metabolism of imrecoxib.
Xu HY; Xie ZY; Zhang P; Sun J; Chu FM; Guo ZR; Zhong DF
Acta Pharmacol Sin; 2006 Mar; 27(3):372-80. PubMed ID: 16490176
[TBL] [Abstract][Full Text] [Related]
3. Formation of 4'-carboxyl acid metabolite of imrecoxib by rat liver microsomes.
Xu HY; Zhang P; Gong AS; Sun YM; Chu FM; Guo ZR; Zhong DF
Acta Pharmacol Sin; 2006 Apr; 27(4):506-12. PubMed ID: 16539853
[TBL] [Abstract][Full Text] [Related]
4. Pharmacokinetics, tissue distribution, metabolism, and excretion of celecoxib in rats.
Paulson SK; Zhang JY; Breau AP; Hribar JD; Liu NW; Jessen SM; Lawal YM; Cogburn JN; Gresk CJ; Markos CS; Maziasz TJ; Schoenhard GL; Burton EG
Drug Metab Dispos; 2000 May; 28(5):514-21. PubMed ID: 10772629
[TBL] [Abstract][Full Text] [Related]
5. Effect of Fluconazole on the Pharmacokinetic Properties of Imrecoxib, a Novel NSAID: A Single-center, Open-label, Self-controlled Study in Healthy Chinese Male Volunteers.
Zuo CZ; Gong Y; Hou XY; Zhang YF; Peng WX; Zhu RH; Zhong DF; Chen XY
Clin Ther; 2018 Aug; 40(8):1347-1356. PubMed ID: 30017171
[TBL] [Abstract][Full Text] [Related]
6. Differences in the In Vivo and In Vitro Metabolism of Imrecoxib in Humans: Formation of the Rate-Limiting Aldehyde Intermediate.
Hou X; Zhou J; Yu S; Zhou L; Zhang Y; Zhong D; Chen X
Drug Metab Dispos; 2018 Sep; 46(9):1320-1328. PubMed ID: 29980580
[TBL] [Abstract][Full Text] [Related]
7. Metabolism, pharmacokinetics, and excretion of a cholesteryl ester transfer protein inhibitor, torcetrapib, in rats, monkeys, and mice: characterization of unusual and novel metabolites by high-resolution liquid chromatography-tandem mass spectrometry and 1H nuclear magnetic resonance.
Prakash C; Chen W; Rossulek M; Johnson K; Zhang C; O'Connell T; Potchoiba M; Dalvie D
Drug Metab Dispos; 2008 Oct; 36(10):2064-79. PubMed ID: 18653742
[TBL] [Abstract][Full Text] [Related]
8. Metabolism and excretion of atorvastatin in rats and dogs.
Black AE; Hayes RN; Roth BD; Woo P; Woolf TF
Drug Metab Dispos; 1999 Aug; 27(8):916-23. PubMed ID: 10421619
[TBL] [Abstract][Full Text] [Related]
9. HPLC-NMR with severe column overloading: fast-track metabolite identification in urine and bile samples from rat and dog treated with [14C]-ZD6126.
Lenz EM; D'Souza RA; Jordan AC; King CD; Smith SM; Phillips PJ; McCormick AD; Roberts DW
J Pharm Biomed Anal; 2007 Feb; 43(3):1065-77. PubMed ID: 17030109
[TBL] [Abstract][Full Text] [Related]
10. Metabolism and disposition of moxonidine in Fischer 344 rats.
He MM; Abraham TL; Lindsay TJ; Chay SH; Czeskis BA; Shipley LA
Drug Metab Dispos; 2000 Apr; 28(4):446-59. PubMed ID: 10725314
[TBL] [Abstract][Full Text] [Related]
11. Urinary metabolite profile of phenyl and o-cresyl glycidyl ether in rats: identification of a novel pathway leading to N-acetylserine O-conjugates.
de Rooij BM; Commandeur JN; Hommes JW; Aalbers T; Groot EJ; Vermeulen NP
Chem Res Toxicol; 1998 Feb; 11(2):111-8. PubMed ID: 9511902
[TBL] [Abstract][Full Text] [Related]
12. Metabolism, excretion, and pharmacokinetics of (3-{[4-tert-butyl-benzyl)-(pyridine-3-sulfonyl)-amino]-methyl}-phenoxy)-acetic acid, an EP2 receptor-selective prostaglandin E2 agonist, in male and female Sprague-Dawley rats.
Johnson KA; Prakash C
Drug Metab Dispos; 2005 Aug; 33(8):1191-201. PubMed ID: 15886349
[TBL] [Abstract][Full Text] [Related]
13. Synthesis and anti-inflammatory activity of the major metabolites of imrecoxib.
Feng Z; Chu F; Guo Z; Sun P
Bioorg Med Chem Lett; 2009 Apr; 19(8):2270-2. PubMed ID: 19286379
[TBL] [Abstract][Full Text] [Related]
14. Comparative metabolism of radiolabeled muraglitazar in animals and humans by quantitative and qualitative metabolite profiling.
Zhang D; Wang L; Raghavan N; Zhang H; Li W; Cheng PT; Yao M; Zhang L; Zhu M; Bonacorsi S; Yeola S; Mitroka J; Hariharan N; Hosagrahara V; Chandrasena G; Shyu WC; Humphreys WG
Drug Metab Dispos; 2007 Jan; 35(1):150-67. PubMed ID: 17062777
[TBL] [Abstract][Full Text] [Related]
15. Pharmacokinetic study of imrecoxib in patients with renal insufficiency.
Pei Q; Xie JL; Huang J; Liu WY; Yang XY; Wang Y; Li W; Tan HY; Zhang H; Yang GP
Eur J Clin Pharmacol; 2019 Oct; 75(10):1355-1360. PubMed ID: 31243478
[TBL] [Abstract][Full Text] [Related]
16. Biotransformation, excretion kinetics, and tissue distribution of an N-pyrrolo[1,2-c]imidazolylphenyl sulfonamide herbicide in rats.
Moghaddam MF; Brown A; Budevska BO; Lam Z; Payne WG
Drug Metab Dispos; 2001 Aug; 29(8):1162-70. PubMed ID: 11454736
[TBL] [Abstract][Full Text] [Related]
17. In vivo and in vitro metabolism of lefucoxib in rats.
Bi X; Meng Z; Chen H; Zhu X; Dou G
J Pharm Biomed Anal; 2008 Sep; 48(1):134-9. PubMed ID: 18538525
[TBL] [Abstract][Full Text] [Related]
18. Simultaneous determination of imrecoxib and its two active metabolites in plasma of hepatic impairment patients by liquid chromatography-tandem mass spectrometry.
Hou X; Dai X; Yang Y; Zhang Y; Zhong D; Chen X
J Chromatogr B Analyt Technol Biomed Life Sci; 2019 Aug; 1122-1123():58-63. PubMed ID: 31153132
[TBL] [Abstract][Full Text] [Related]
19. Disposition of triprolidine in the male beagle dog.
McNulty MJ; Deal DL; Page TL; Chandrasurin P; Findlay JW
Drug Metab Dispos; 1992; 20(6):928-35. PubMed ID: 1362948
[TBL] [Abstract][Full Text] [Related]
20. Excretion of metabolites in urine and faeces from rats dosed with the heterocyclic amine, 2-amino-9H-pyrido[2,3-b]indole (AalphaC).
Frederiksen H; Frandsen H
Food Chem Toxicol; 2004 Jun; 42(6):879-85. PubMed ID: 15110096
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
